01811nam a22005657a 4500 DOH 20210505162300.0 210505b ||||| |||| 00| 0 eng d Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2 : a randomised, double-blind, placebo-controlled, phase 1 trial / Keith J Chappell [and twenty four others] Lancet Infect Dis . 2021 Apr 19;S1473-3099 (21) 00200-0. doi: 10.1016/S1473-3099(21)00200-0. COVID-19 Vaccines immunology Placebo Effects Adjuvants, Immunologic Chappell, Keith J Mordant, Francesca L Li, Zheyi Wijesundara, Danushka K Ellenberg, Paula Lackenby, Julia A Cheung, Stacey T M Modhiran, Naphak Avumegah, Michael S Henderson, Christina L Hoger, Kym Griffin, Paul Bennet, Jillian Hensen, Luca Zhang, Wuji Nguyen, Thi H O Marrero-Hernandez, Sara Selva, Kevin J Chung, Amy W Tran, Mai H Tapley, Peter Barnes, James Reading, Patrick C Nicholson, Suellen Corby, Stavroula Holgate, Thomas Wines, Bruce D Hogarth, P Mark Kedzierska, Katherine Purcell, Damian F J Ranasinghe, Charani Subbarao, Kanta Watterson, Daniel Young, Paul R Munro, Trent P JA 4418 4418 0 0 nlm 0 0 DOHCL DOHCL ElectronicRes 2021-05-05 0 COVID-19-000195 D0001C000195 2021-05-05 00:00:00 2021-05-05 JA